Skip to content

ActiveOps – Delivering Growth

Calculus portfolio company ActiveOps provides best in class solutions to organisations looking to optimise the use of their technical and human resources. Since Calculus invested in March 2014, the Company has grown significantly. Total revenues have grown by over 130%, with the most valuable SaaS revenues growing even faster. This recently produced video provides an overview … Continued

Synpromics awarded Innovate UK grant

Calculus portfolio company, Synpromics, has announced a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals. The 18-month project has been made possible through the award of a £235,000 grant, part of the medicines manufacturing competition from Innovate UK. Dr Michael Roberts, Founder & CSO of Synpromics: … Continued

Calculus EIS fund - now open

Calculus EIS Fund – Next close 27 April

The multi award winning Calculus EIS Fund has an upcoming tranche close date of 27 April. The next tranche close following this is 29 June. If you, or your clients are interested in investing, contact the team on [email protected] or 020 7493 4940. Access a diversified portfolio of established companies through the Calculus EIS Fund … Continued

Blu Wireless Technology named as “Key Innovators” in the European Commission’s Innovation Radar Platform

On Tuesday April 10, 2018, Blu Wireless Technology was named by the European Commission as a key innovator in its Innovation Radar Platform being launched the same day. This acknowledgement is bestowed as a result of their involvement in the Horizon 2020 framework, the largest research and innovation funding programme in Europe. More specifically within the … Continued

Calculus completes two further investments

On 29 March, Calculus completed two follow-on investments into portfolio companies Weedingtech and Quai. These investments represent further funding and support for businesses we have previously backed as they continue to grow. Weedingtech is a multi-award winning cleantech company and Quai are specialists in digital administration. Weedingtech is a world leader in herbicide-free weed and … Continued

C4X CEO discusses landmark Indivior deal

Clive Dix, Chief Executive of C4X Discovery Holdings plc (LON:C4XD), discusses with Proactive’s Andrew Scott their licensing deal with FTSE 250-listed Indivior for its addiction behaviour suppressant, C4X3256. It is the first major partnership for C4X, which will receive US$10mn up front and a further US$284mn dependent on how successful the drug proves. [youtube id=”0oq-qiSQGo0″]